StockData
Turn Therapeutics Inc. logo

Turn Therapeutics Inc. (TTRX) stock

TTRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 2/30
$8.55+0.00 (0.00%)

Close on Nov 17, 2026Market cap $254.69MP/E –Yield –

Turn Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Turn Therapeutics's operating cash flow for the twelve months ending Sep 30, 2026 was -$5.28M. For fiscal 2025 it was -$2.56M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.56M–
FY2024Dec 31, 2024-$1.36M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$1.55M–
Q2 FY2026Jun 30, 2026-$923.36K–
Q1 FY2026Mar 31, 2026-$1.63M–
Q4 FY2025Dec 31, 2025-$1.18M–
Q3 FY2025Sep 30, 2025-$588.61K–
Q2 FY2025Jun 30, 2025-$499.97K–
Q1 FY2025Mar 31, 2025-$298.06K–
Q4 FY2024Dec 31, 2024-$430.55K–

More Turn Therapeutics figures

See a number that looks wrong?